David Einhorn's position in Teva- Pharmaceutical Industries is currently worth $9.24M. That's 0.39% of their equity portfolio (24th largest holding). David Einhorn acquired their 268k shares in Q4 2023. So far they never sold any shares in the company. The stake costed the investor $2.51M, netting the investor a gain of 269% so far.